AAAAAA
Results: 1-25/38
Authors:
Shaldivin, A
Kaptsan, A
Belmaker, RH
Einat, H
Grisaru, N
Citation: A. Shaldivin et al., Transcranial magnetic stimulation in an amphetamine hyperactivity model ofmania, BIPOL DIS, 3(1), 2001, pp. 30-34
Authors:
Kozlovsky, N
Belmaker, RH
Agam, G
Citation: N. Kozlovsky et al., Low GSK-3 activity in frontal cortex of schizophrenic patients, SCHIZOPHR R, 52(1-2), 2001, pp. 101-105
Authors:
Nemets, B
Fux, M
Levine, J
Belmaker, RH
Citation: B. Nemets et al., Combination of antidepressant drugs: The case of inositol, HUM PSYCHOP, 16(1), 2001, pp. 37-43
Authors:
Shaldubina, A
Agam, C
Belmaker, RH
Citation: A. Shaldubina et al., The mechanism of lithium action: State of the art, ten years later, PROG NEUR-P, 25(4), 2001, pp. 855-866
Authors:
Gelber, D
Levine, J
Belmaker, RH
Citation: D. Gelber et al., Effect of inositol on bulimia nervosa and binge eating, INT J EAT D, 29(3), 2001, pp. 345-348
Authors:
Einat, H
Clenet, F
Shaldubina, A
Belmaker, RH
Bourin, M
Citation: H. Einat et al., The antidepressant activity of inositol in the forced swim test involves 5-HT2 receptors, BEH BRA RES, 118(1), 2001, pp. 77-83
Authors:
Einat, H
Belmaker, RH
Citation: H. Einat et Rh. Belmaker, The effects of inositol treatment in animal models of psychiatric disorders, J AFFECT D, 62(1-2), 2001, pp. 113-121
Authors:
Dossenbach, MRK
Kratky, P
Schneidman, M
Grundy, SL
Metcalfe, S
Tollefson, GD
Belmaker, RH
Citation: Mrk. Dossenbach et al., Evidence for the effectiveness of olanzapine among patients nonresponsive and/or intolerant to risperidone, J CLIN PSY, 62, 2001, pp. 28-34
Authors:
Dobrusin, M
Corbex, M
Kremer, I
Murad, I
Muhaheed, M
Bannoura, I
Muller, DJ
Schulze, TG
Reshef, A
Blanaru, M
Gathas, S
Rietschel, M
Belmaker, RH
Maier, W
Ebstein, RP
Citation: M. Dobrusin et al., No evidence for linkage by transmission disequilibrium test analysis of microsatellite marker D22S278 and schizophrenia in a Palestinian Arab and in a German population, AM J MED G, 105(4), 2001, pp. 328-331
Authors:
Murad, I
Kremer, I
Dobrusin, M
Muhaheed, M
Bannoura, I
Muller, DJ
Schulze, TG
Reshef, A
Blanaru, M
Gathas, S
Tsenter, V
Rietschel, M
Belmaker, RH
Maier, W
Ebstein, RP
Citation: I. Murad et al., A family-based study of the Cys23Ser 5HT2C serotonin receptor polymorphismin schizophrenia, AM J MED G, 105(3), 2001, pp. 236-238
Authors:
van Calker, D
Belmaker, RH
Citation: D. Van Calker et Rh. Belmaker, The high affinity inositol transport system implications for the pathophysiology and treatment of bipolar disorder, BIPOL DIS, 2(2), 2000, pp. 102-107
Authors:
Benjamin, J
Osher, Y
Kotler, M
Gritsenko, I
Nemanov, L
Belmaker, RH
Ebstein, RP
Citation: J. Benjamin et al., Association between tridimensional personality questionnaire (TPQ) traits and three functional polymorphisms: dopamine receptor D4 (DRD4), serotonin transporter promoter region (5-HTTLPR) and catechol O-methyltransferase (COMT), MOL PSYCHI, 5(1), 2000, pp. 96-100
Authors:
Lisanby, SH
Belmaker, RH
Citation: Sh. Lisanby et Rh. Belmaker, Animal models of the mechanisms of action of repetitive transcranial magnetic stimulation (rTMS): Comparisons with electroconvulsive shock (ECS), DEPRESS ANX, 12(3), 2000, pp. 178-187
Authors:
Ebstein, RP
Benjamin, J
Belmaker, RH
Citation: Rp. Ebstein et al., Genetics of personality dimensions, CUR OPIN P, 13(6), 2000, pp. 617-622
Authors:
Nemets, B
Geller, V
Grisaru, N
Belmaker, RH
Citation: B. Nemets et al., Olanzapine treatment of clozapine-induced NMS, HUM PSYCHOP, 15(2), 2000, pp. 77-78
Authors:
Wolfson, M
Einat, H
Bersudsky, Y
Berkin, V
Belmaker, RH
Hertz, L
Citation: M. Wolfson et al., Nordidemnin potently inhibits inositol uptake in cultured astrocytes and dose-dependently augments lithium's proconvulsant effect in vivo, J NEUROSC R, 60(1), 2000, pp. 116-121
Authors:
Benjamin, J
Osher, Y
Lichtenberg, P
Bachner-Melman, R
Gritsenko, I
Kotler, M
Belmaker, RH
Valsky, V
Drendel, M
Ebstein, RP
Citation: J. Benjamin et al., An interaction between the catechol O-methyltransferase and serotonin transporter promoter region polymorphisms contributes to Tridimensional Personality Questionnaire persistence scores in normal subjects, NEUROPSYCHB, 41(1), 2000, pp. 48-53
Authors:
Shapiro, J
Belmaker, RH
Biegon, A
Seker, A
Agam, G
Citation: J. Shapiro et al., Scyllo-inositol in post-mortem brain of bipolar, unipolar and schizophrenic patients, J NEURAL TR, 107(5), 2000, pp. 603-607
Authors:
Einat, H
Shaldubina, A
Belmaker, RH
Citation: H. Einat et al., Epi-inositol: A potential antidepressant, DRUG DEV R, 50(3-4), 2000, pp. 309-315
Authors:
Osher, Y
Mandel, B
Shapiro, E
Belmaker, RH
Citation: Y. Osher et al., Rorschach markers in offspring of manic-depressive patients, J AFFECT D, 59(3), 2000, pp. 231-236
Authors:
Dossenbach, MRK
Beuzen, JN
Avnon, M
Belmaker, RH
Elizur, A
Mark, M
Munitz, H
Schneidman, M
Shoshani, D
Kratky, P
Grundy, SL
Tollefson, GD
Citation: Mrk. Dossenbach et al., The effectiveness of olanzapine in treatment-refractory schizophrenia whenpatients are nonresponsive to or unable to tolerate clozapine, CLIN THER, 22(9), 2000, pp. 1021-1034
Authors:
Kremer, I
Rietschel, M
Dobrusin, M
Mujaheed, M
Murad, I
Blanaru, M
Bannoura, I
Muller, DJ
Schulze, TG
Reshef, A
Gathas, S
Schwab, S
Wildenauer, D
Bachner-Melman, R
Belmaker, RH
Maier, W
Ebstein, RP
Citation: I. Kremer et al., No association between the dopamine D3 receptor Bal I polymorphism and schizophrenia in a family-based study of a Palestinian Arab population, AM J MED G, 96(6), 2000, pp. 778-780
Authors:
Ebstein, RP
Benjamin, J
Belmaker, RH
Citation: Rp. Ebstein et al., Personality and polymorphisms of genes involved in aminergic neurotransmission, EUR J PHARM, 410(2-3), 2000, pp. 205-214
Authors:
Wolfson, M
Bersudsky, Y
Zinger, E
Simkin, M
Belmaker, RH
Hertz, L
Citation: M. Wolfson et al., Chronic treatment of human astrocytoma cells with lithium, carbamazepine or valproic acid decreases inositol uptake at high inositol concentrations but increases it at low inositol concentrations, BRAIN RES, 855(1), 2000, pp. 158-161
Authors:
Kozlovsky, N
Belmaker, RH
Agam, G
Citation: N. Kozlovsky et al., Low GSK-3 beta immunoreactivity in postmortem frontal cortex of schizophrenic patients, AM J PSYCHI, 157(5), 2000, pp. 831-833